MedPath

A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser in Asian Eyes Using LASIK

Phase 4
Conditions
Myopia
Hyperopia
Presbyopia
Registration Number
NCT01977807
Lead Sponsor
Technolas Perfect Vision GmbH
Brief Summary

This clinical study has been planned to evaluate the safety and effectiveness of common treatment algorithms using 500 Hz laser repetition rate.

Detailed Description

This clinical study has been planned to evaluate the safety and effectiveness of the excimer laser treatment algorithms Proscan, Zyoptix and Supracor of the 500 Hz laser system for ametropia and/or presbyopia when performed on the cornea of virgin eyes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
For Proscan and Zyoptix: - The percentage of treated eyes within +/- 0.50D of target refraction. For Supracor: - The percentage of treated eyes with a best corrected high contrast distance VA of Snellen 20/25 (6/7.5 or 0.1 logMAR) or betterMyopia: 6 months, Hyperopia 12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Asian Eye Institut

🇵🇭

Manila, Philippines

Asian Eye Institut
🇵🇭Manila, Philippines
Mary Ann Catacutan, Dr.
Contact
mtcatacutan@asianeyeinstitute.com
Gino Antonio Lagrosa
Contact
gclagrosa@asianeyeinstitute.com
Robert Ang, Dr.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.